PhD Club: Decoding CuEt-Mediated Immune Activation, Signaling and Immunogenic Changes in Cancer Cells by Viktor Valentini
Wednesday June 10, 2026 / 9:00 AM / seminary room 1.09
Prague hosted the Czech EATRIS Spotlight Programme event: Experts discussed the future of translational medicine
The Czech EATRIS Spotlight Programme Event took place on June 1, 2026 at the Kaiserstein Palace in Prague, bringing together leading experts to support translational medicine and strengthen collaboration among researchers.
Read more
IMTM at the AACR Annual Meeting 2026 in San Diego
This year, IMTM was once again represented by Marián Hajdúch, Petr Džubák, Josef Srovnal, and Martin Mistrík at the AACR Annual Meeting 2026, taking place April 17–22 in San Diego.
Read more
The Czech Annual Cancer Research Meeting 2025 proudly celebrated it 20th anniversary
From 24-26 November 2025, more than 300 leading figures from Czech and international scientific and biomedical communities gathered in Olomouc for the Czech Annual Cancer Research Meeting. This year, the meeting proudly marked its 20th anniversary!
Read more
NICR & EATRIS-CZ: Platform for accelerating biomedical innovations
The major research infrastructure EATRIS connects more than 120 research institutions and 11 Czech centers, including NICR (National Institute for Cancer Research). Together, we build an infrastructure that accelerates the translation of basic research results into clinical practice. Watch the video.
Read moreNews
Prague hosted the Czech EATRIS Spotlight Programme event: One hundred experts discussed the future of translational medicine in Europe
The Czech EATRIS Spotlight Programme Event took place on June 1, 2026 at the Kaiserstein Palace in Prague, bringing together leading experts to support translational medicine and strengthen collaboration among researchers.
PERMED: T2BA Consortium meeting + T2BA Scientific Board meeting (NCC Council)
The T2BA meetings will be hold on June 11-12, 2026 at the IMTM in the seminary room 1.09. Full program is available here.
PhD Club: SureQuant™ applied in tear proteomics by Denisa Kroupová
Wednesday June 3, 2026 / 9:00 AM / seminary room 1.09
PhD Club: Advanced plasmonic microthermal technology: from protein aggregates to potential proteomic discovery by Adam Kiska
May 26, 2026 / 9:00 AM / seminary room 1.09
IMTM YouTube channel
Featured publications
Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery.
Nature Communications.
2023,
14(1),
8437,
ISSN: 2041-1723,
IF: 16.6,
PMID: 38114468.
The isocyanide SN2 reaction.
Nature Communications.
2023,
14(1),
5807,
ISSN: 2041-1723,
IF: 16.6,
PMID: 37726293.
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis.
American Journal of Hematology.
2023,
98(8),
1265-1276,
ISSN: 0361-8609 ,
IF: 12.8,
PMID: 37350302.
Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association.
2023,
-,
-,
ISSN: 1552-5260,
IF: 16.655,
PMID: 36825691.
Synthesis of Polycyclic Hetero-Fused 7-Deazapurine Heterocycles and Nucleosides through C-H Dibenzothiophenation and Negishi Coupling.
Journal of the American Chemical Society.
2022,
144(42),
19437-19446,
ISSN: 0002-7863,
IF: 16.383,
PMID: 36245092.
Visualization of Sentinel Lymph Nodes with Mannosylated Fluorescent Nanodiamonds.
Advanced Functional Materials.
2022,
32(23),
2109960,
ISSN: 1616-301X,
IF: 18.808,
Lipidomic profiling of human serum enables detection of pancreatic cancer.
Nature Communications.
2022,
13(1),
124,
ISSN: 2041-1723,
IF: 14.919,
PMID: 35013261.
RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis.
Cell Death and Differentiation.
2022,
29(3),
687-696,
ISSN: 1350-9047,
IF: 15.828,
PMID: 34611297.
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.
Nature Biotechnology.
2021,
39(9),
1151-60,
ISSN: 1087-0156,
IF: 54.908,
PMID: 34504347.
Technology & services
Featured research projects
Research infrastructures
